Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation

Pure red cell aplasia (PRCA) following allogeneic hematopoietic stem cell transplantation (HSCT) has been mostly reported in situations involving major ABO incompatibility between donor and recipient. Conventional treatments such as plasma exchange, erythropoietin, and steroid are often unsatisfacto...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Sung-Hoon Jung, Jae-Sook Ahn, Deok-Hwan Yang, Hyung Chul Park, Soo-Young Bae, Yeo-Kyeoung Kim, Hyeoung-Joon Kim, Je-Jung Lee
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Karger Publishers 2012-02-01
Σειρά:	Case Reports in Oncology
Θέματα:	Rituximab ABO compatibility Pure red cell aplasia Allogeneic stem cell transplantation
Διαθέσιμο Online:	http://www.karger.com/Article/FullText/337022
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!